Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

Amanda B. Spurdle, Louise Marquart, Lesley McGuffog, Sue Healey, Olga Sinilnikova, Fei Wan, Xiaoqing Chen, Jonathan Beesley, Christian F. Singer, Anne-Catharine Dressler, Daphne Gschwantler-Kaulich, Joanne L. Blum, Nadine Tung, Jeff Weitzel, Henry Lynch, Judy Garber, Douglas F. Easton, Susan Peock, Margaret Cook, Clare T. OliverDebra Frost, Don Conroy, D. Gareth Evans, Fiona Lalloo, Ros Eeles, Louise Izatt, Rosemarie Davidson, Carol Chu, Diana Eccles, Christina G. Selkirk, Mary Daly, Claudine Isaacs, Dominique Stoppa-Lyonnet, Olga M. Sinilnikova, Bruno Buecher, Muriel Belotti, Sylvie Mazoyer, Laure Barjhoux, Carole Verny-Pierre, Christine Lasset, Helene Dreyfus, Pascal Pujol, Marie-Agnes Collonge-Rame, Matti A. Rookus, Senno Verhoef, Mieke Kriege, Nicoline Hoogerbrugge, Margreet G. E. M. Ausems, Tuomas Heikkinen, Heli Nevanlinna, GEMO Study Collaborators, SWE-BRCA

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalCancer Epidemiology, Biomarkers & Prevention
Volume20
Issue number5
Pages (from-to)1032-1038
Number of pages7
ISSN1055-9965
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • UNKNOWN CLINICAL-SIGNIFICANCE
  • DNA-SEQUENCE VARIANTS
  • OVARIAN-CANCER
  • HAPLOTYPE FREQUENCIES
  • CYS557SER ALLELE
  • SUSCEPTIBILITY
  • IDENTIFICATION
  • POPULATION
  • DISEASE
  • COHORT
  • 3123 Gynaecology and paediatrics

Cite this